glp-1 drugs and alzheimer's Drug Fails to Quell in Novo Nordisk Trials GLP-1 Microdosing, Brain Health &

European Medicines Agency website

Expanding Clinical Indications: Recent trial results have fundamentally reshaped the GLP-1 value proposition

So researchers looked at the medical records of more than 3,000 people with hormone receptor-positive DCIS on hormonal therapy and GLP-1s, as well as an equal number of people with hormone receptor-positive DCIS who were not taking GLP-1s

And by month six, tirzepatide users have typically lost double what phentermine users have achieved

HR 0.86

Bad actors continue selling illicit tirzepatide made with substandard foreign ingredients despite the FDA warning that it puts Americans at heightened risk, and we continue to find critical safety and effectiveness issues in tirzepatide knockoffs, including bacterial contamination, high endotoxin levels and other impurities